We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 2.86% | 18.00 | 17.50 | 18.50 | 18.00 | 17.50 | 17.50 | 242,114 | 11:30:47 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/11/2016 12:24 | MM lots of 10k being sold, just for clarification not me. | john henry | |
28/11/2016 11:29 | IMHO there is a background buyer, WINS on the bid early doors. 10k sells were taken without to much fallback. | john henry | |
28/11/2016 10:40 | Get the impression someone talking it up to sell another 100k, lol! | alphapig | |
28/11/2016 10:00 | Once opti's first cardio products are launched, the company will really start to get noticed. I'm actually expecting a media frenzy especially with all the bad press associated with statins. Our products are natural. It's just a matter of time IMO. | parob | |
28/11/2016 09:37 | I'm surprised the market isn't picking up on the story. Starting to get media attention. | john henry | |
28/11/2016 09:24 | Potentially huge news for Opti. | john henry | |
28/11/2016 09:11 | Proactive Investors also pointing to the Telegraph article on twitter: Proactive Investors ?@proactive_uk 55s55 seconds ago@optibiotix Concerns over Statins create opportunity for OptiBiotix's products #OPTI OptiBiotix Health PLC | parob | |
28/11/2016 09:08 | I see SOH has commented on the Telegraph article I posted at the weekend: http://www.directors | parob | |
28/11/2016 08:53 | disappointing thus far, started up and then(all)selling increasing, bah | neftanikoff | |
27/11/2016 12:13 | Daily trading dynamics certainly seem to be shifting in favour of buyers the last few days. Selling is definitely reducing, apart from my 100k lol | john henry | |
26/11/2016 13:15 | There is a new 2 minute video on YouTube on Opti posted today by 'why invest in'. Not very exciting, but more coverage. | mouse20 | |
26/11/2016 12:47 | What a time to bring a a natural cholesterol reducing food/supplement to market? Competition weakening whilst our 0.1g dose has shown in clinicals brilliant results. Up the dose to say a 1g 10x the effect? A bit optimistic but possible. Optibiotixs optibiotic platform has just produced a sugar that increases the cholesterol reducing effect theeefold of the probiotic strain. In the future we'll see an 'optibiotic' as a probiotic prebiotic combination. This probiotic in its current form is as good as any other on the market but there most definitely is 'more to come' further down the line which has genuine potential to destroy the statin market. | riskybusiness1 | |
26/11/2016 11:31 | More roads leading to OPTI! | elrico | |
26/11/2016 11:21 | I understated the Pfizer expansion budget that has been cancelled. It was Euro 400m. | owenmo | |
26/11/2016 11:18 | Thanks Parob; No scientific evidence supporting statins. And news to-day from these parts:"Pfizer cancels E400,000 expansion of its Dublin plant following failure of key cholesterol-lowering drug." More grist to the mill. | owenmo | |
26/11/2016 09:24 | Parob, couldn't agree more. Opti are at the forefront and Gofigure, which does work, gives me greater confidence for the future. I think the next 6 months will see a significant re-rate for the shares. | rafboy | |
26/11/2016 08:39 | "'No scientific evidence' for the use of statins, experts claim" "Lancet study on statins was 'fundamentally flawed', critics say" "The Great Cholesterol & Statin Con" Stacks of negative coverage this week on the use of statins, both print and broadcast - and I'm sure it will continue next year too. Looks like our cardiovascular products will be hitting the shelves at just the right time. And all backed up by science, patents and publications. The Cleveland Clinic recently unveiled that it believes the Microbiome will be the top medical innovation most likely to be a game changer in 2017. I remember Elrico once mentioning that this new science will be the new bubble for investors to be in and I couldn't agree more. I'm expecting fireworks for OPTI next year. As the Microbiome becomes more and more mainstream it is better to be invested before the herds arrive - and they will. We are so ahead of the curve. | parob | |
25/11/2016 21:44 | I'm liking the investment calculator on the Opti website...BTW best wishes Elrico, have a great weekend. | 1bokke | |
25/11/2016 17:59 | The rapid increase in publications and patents is an unmissable sign this space will ignite very soon. A scientific tipping point in the way we treat, manage and prevent disease. A shift away from pharmaceutical products with adverse side effects, but gaining the same health benefits. If it is png i used the align lawsuit comment above as an example as to why they may want to slow things down. Align is awful, old school probiotics that 'may' have a health benefit compared to what opti is producing. It includes a number of strains with variable clinical data and most importantly no understanding of its mechanism of action. The next generation of probiotics are on their way. | riskybusiness1 | |
25/11/2016 17:51 | Probably get more sense..... Happy birthday! | dogwalker | |
25/11/2016 17:37 | £188 for 8 boxes. I forgot it was BF. Thanks for reminder Joyjoy.Have good weekend all. I will with a birthday bash so you'll get no sense from me this weekend. Yeah, yeah I know ;-) | elrico | |
25/11/2016 16:14 | Bought the Go Figure bars today using that Black Friday discount code posted here the other day, thank you to the poster. Will keep for January... To be used to loose excess weight probably gained over Christmas.. Will let you know how I get on with them. | joyjoy13 | |
25/11/2016 16:11 | That Align product was launched in 2009, so let's hope OPTI has products that tick the appropriate box that Proctor and Gamble are looking for... | joyjoy13 | |
25/11/2016 16:02 | Mar are you looking at the bid low ? As the mid low was 60.5p | john henry |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions